Overview Performance Dividends Fundamentals Peer Group Correlations Pair Trades Institutions Insider Forecasts Options

Performance of RPRX Royalty Pharma Plc | -16.8% in 12m

Compare RPRX with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?

Compare Royalty Pharma Plc with its related Sector/Index XLV

Compare Royalty Pharma Plc with its related Sector/Index XLV

Performance Duell RPRX vs XLV

TimeFrame RPRX XLV
1 Day -1.22% 0.25%
1 Week 1.03% 0.28%
1 Month -2.67% -1.67%
3 Months 3.27% -0.77%
6 Months 3.77% 10.69%
12 Months -16.8% 7.15%
YTD 1.22% 1.84%
Rel. Perf. 1m -0.02
Rel. Perf. 3m -0.20
Rel. Perf. 6m -0.65
Rel. Perf. 12m -2.55

Is Royalty Pharma Plc a good stock to buy?

Partly, yes. Based on ValueRay Fundamental Analyses, Royalty Pharma Plc (NASDAQ:RPRX) is currently (May 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 36.41 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of RPRX as of May 2024 is 25.09. This means that RPRX is currently overvalued and has a potential downside of -11.69% (Sold with Premium).

Is RPRX a buy, sell or hold?

  • Strong Buy: 6
  • Buy: 3
  • Hold: 1
  • Sell: 0
  • Strong Sell: 0
Royalty Pharma Plc has received a consensus analysts rating of 4.50. Therefor, it is recommend to buy RPRX.
Values above 0%: RPRX is performing better - Values below 0%: RPRX is underperforming

Compare RPRX with Broad Market Indices

Symbol 1w 1m 6m 12m
US S&P 500 SPY 0.79% -1.29% -14.42% -42.51%
US NASDAQ 100 QQQ 0.40% -1.54% -14.63% -52.58%
US Dow Jones Industrial 30 DIA 0.26% -2.18% -10.70% -33.89%
German DAX 40 DBXD 1.71% -1.73% -14.93% -29.18%
UK FTSE 100 ISFU 0.22% -6.27% -10.18% -25.56%
Shanghai Shenzhen CSI 300 CSI 300 -0.78% -6.69% 1.29% -6.17%
Hongkong Hang Seng HSI -3.03% -10.86% 5.31% -2.19%
Japan Nikkei 225 EXX7 -0.70% 0.31% -10.97% -35.45%
India NIFTY 50 INDA 0.65% -4.03% -15.56% -44.42%
Brasil Bovespa EWZ -0.73% -4.24% -0.71% -36.01%

RPRX Royalty Pharma Plc vs. Sectors

Symbol 1w 1m 6m 12m
Communication Services XLC -0.27% 0.13% -15.89% -55.60%
Consumer Discretionary XLY 2.19% -2.15% -7.57% -38.62%
Consumer Staples XLP 0.96% -4.76% -8.08% -18.00%
Energy XLE 4.99% 2.95% -6.17% -36.18%
Financial XLF 1.55% -0.22% -17.68% -44.47%
Health Care XLV 0.75% -1.00% -6.92% -23.96%
Industrial XLI 1.60% -0.36% -18.43% -42.26%
Materials XLB 1.85% 0.82% -11.64% -31.51%
Real Estate XLRE 0.62% 0.87% -5.00% -19.22%
Technology XLK 0.10% -0.78% -13.84% -51.83%
Utilities XLU -0.94% -7.66% -9.07% -19.32%
Aerospace & Defense XAR -0.54% -3.78% -12.74% -40.89%
Biotech XBI -4.19% -2.45% -25.01% -22.22%
Homebuilder XHB 0.32% 0.43% -34.37% -66.73%
Retail XRT 0.73% -1.00% -16.30% -38.57%

RPRX Royalty Pharma Plc vs. Commodities

Symbol 1w 1m 6m 12m
Oil USO 6.53% 6.15% 3.48% -36.01%
Natural Gas UNG -4.07% -8.05% 46.33% 19.70%
Gold GLD 2.52% -1.66% -12.38% -30.41%
Silver SLV 3.49% 0.57% -11.13% -19.57%
Copper CPER 3.51% -9.57% -18.83% -35.46%

Returns of RPRX vs. Yields & Bonds

Symbol 1w 1m 6m 12m
iShares 20+ Years Bond TLT -0.29% -1.32% -1.81% -5.72%
iShares High Yield Corp. Bond HYG 0.20% -3.54% -3.46% -26.36%
Does Royalty Pharma Plc outperform its market, is RPRX a Sector Leader?
No, over the last 12 months Royalty Pharma Plc (RPRX) made -16.81%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 7.15%.
Over the last 3 months RPRX made 3.27%, while XLV made -0.77%.
Period RPRX XLV S&P 500
1 Month -2.67% -1.67% -1.38%
3 Months 3.27% -0.77% 4.13%
12 Months -16.81% 7.15% 25.70%